Iron Deficiency (ID) in Infants

NCT02484274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 830

Last updated 2026-03-04

No results posted yet for this study

Summary

ID in children is the most frequent micronutrient deficiency in industrialized countries, including France. ID induces neurological impairment reducing cognitive, motor, and behavioral capacities in children in the short and long term.

The purpose of this study is to evaluate the principal determinants of ID in France in two-year-old children and to improve strategies for prevention and screening.

The main objective is to study the association between iron status in two-year-old infants living in France and the consumption of toddler milk formula after taking non-dairy iron ingestion, parental socioeconomic status and educational level into account.

The secondary objectives are the following :

* to estimate the prevalence of ID and ID anemia in 2-year-old children living in France.
* to improve clinical tools for ID screening. to improve strategies for laboratory screening.

Conditions

  • Iron Deficiency in Young Children Living in France

Interventions

BIOLOGICAL

Blood samples

1 blood sample of 9 ml. 3-day food diary , according to the European Food Safety Authority methodology

Sponsors & Collaborators

  • Association Clinique Thérapeutique Infantile du val de Marne

    collaborator OTHER
  • Association Française de Pédiatrie Ambulatoire- AFPA

    collaborator UNKNOWN
  • CERBA

    collaborator UNKNOWN
  • Laboratoire de Biochimie, CHU Louis Mourier

    collaborator UNKNOWN
  • INSERM 1153, Centre de Recherche Epidémiologique et Biostatistique

    collaborator UNKNOWN
  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER
  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Martin Chalumeau, MD, PhD · INSERM UMR 1153

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Months
Max Age
26 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-06
Primary Completion
2018-01-15
Completion
2018-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02484274 on ClinicalTrials.gov